These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6292096)

  • 1. Fate of vaccines of Propionibacterium acnes after phagocytosis by murine macrophages.
    Pringle AT; Cummins CS; Bishop BF; Viers VS
    Infect Immun; 1982 Oct; 38(1):371-4. PubMed ID: 6292096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cell surface of Propionibacterium acnes: effect of specific chemical modifications on the ability of vaccines to produce splenomegaly in mice.
    Pringle AT; Cummins CS
    Can J Microbiol; 1982 Apr; 28(4):375-82. PubMed ID: 7093818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Observations on the nature of the determinants in anaerobic coryneforms which produce splenomegaly.
    Cummins CS; Stimpson SA; Tuttle RL; Weck CJ
    J Reticuloendothel Soc; 1981 Jan; 29(1):1-13. PubMed ID: 6259348
    [No Abstract]   [Full Text] [Related]  

  • 4. Relationship between cell wall synthesis in Propionibacterium acnes and ability to stimulate the reticuloendothelial system.
    Pringle AT; Cummins CS
    Infect Immun; 1982 Feb; 35(2):734-7. PubMed ID: 7056584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical properties of the principle in C. parvum that produces splenomegaly in mice.
    Riveros-Moreno V; Niblock A
    Immunology; 1979 Mar; 36(3):495-9. PubMed ID: 220183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity and lymphoreticular stimulation properties of fractions isolated from Corynebacterium parvum.
    Cantrell JL; Wheat RW
    Cancer Res; 1979 Sep; 39(9):3554-63. PubMed ID: 225023
    [No Abstract]   [Full Text] [Related]  

  • 7. Fatty acid composition of a Propionibacterium acnes vaccine and its relationship to immunostimulatory activity.
    Julák J; Bednár M; Turecek F; Mára M
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Dec; 258(2-3):296-309. PubMed ID: 6532023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunomodulating properties of Acnevac vaccine].
    Marcinkiewicz J; Bryniarski K; Nowak B; Dzielska D; Payerhin F
    Med Dosw Mikrobiol; 1991; 43(3-4):167-74. PubMed ID: 1840429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biphasic protection against bacterial infection in mice induced by vaccination of Propionibacterium acnes.
    Kobayashi F; Nagoya T; Koshi T; Saino Y
    Infect Immun; 1980 Feb; 27(2):391-6. PubMed ID: 7380536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The correlation of susceptibility of different Propionibacterium strains to macrophage killing and antitumor activity.
    Roszkowski W; Ko HL; Roszkowski K; Szmigielski S; Jeljaszewicz J; Pulverer G
    Med Microbiol Immunol; 1980; 169(1):1-8. PubMed ID: 7464684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of various coryneforms on mononuclear phagocyte system function and on production of tumour necrosis factor in mice.
    Bloksma N; de Leeuw R; Hofhuis FM; Westerdaal NA; Benaissa-Trouw B; Willers JM
    Ann Immunol (Paris); 1983; 134C(1):159-64. PubMed ID: 6190428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acne-like chronic inflammatory activity of Propionibacterium acnes preparations in an animal model: correlation with ability to stimulate the reticuloendothelial system.
    De Young LM; Spires DA; Ballaron SJ; Cummins CS; Young JM; Allison AC
    J Invest Dermatol; 1985 Sep; 85(3):255-8. PubMed ID: 3161957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study on the immunostimulatory potency of different Propionibacterium strains.
    Ko HL; Roszkowski W; Jeljaszewicz J; Pulverer G
    Med Microbiol Immunol; 1981; 170(1):1-9. PubMed ID: 7300800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravenous injection of two different strains of Corynebacterium parvum in the mouse.
    Sadler TE; Jones PD; Castro JE; Lampert IA
    Br J Exp Pathol; 1979 Dec; 60(6):627-31. PubMed ID: 540104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages largely contribute to heterologous anti-Propionibacterium acnes antibody-mediated protection from Actinobacillus pleuropneumoniae infection in mice.
    Ma Q; Sun C; Yang F; Wang L; Qin W; Xia X; Feng X; Du C; Gu J; Han W; Lei L
    Microbiol Immunol; 2015 Mar; 59(3):166-73. PubMed ID: 25644652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage activation and mobilization in nude mice by Corynebacterium parvum and pyran: a functional and histologic study.
    Stinnett JD; Majeski JA
    J Surg Oncol; 1980; 14(4):327-32. PubMed ID: 6969333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumour growth, phagocytic activity and antibody response in Corynebacterium parvum-treated mice.
    Woodruff MF; McBride WH; Dunbar N
    Clin Exp Immunol; 1974 Jul; 17(3):509-18. PubMed ID: 4549691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Propionibacterium acnes and related organisms by precipitin tests with trichloroacetic acid extracts.
    Cummins CS
    J Clin Microbiol; 1976 Aug; 2(2):104-10. PubMed ID: 972178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of C. parvum on the number and activity of macrophages in primary and transplanted murine fibrosarcomas.
    McBride WH; Woodruff MF; Forbes GM; Moore K
    Br J Cancer; 1982 Sep; 46(3):448-51. PubMed ID: 7126431
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of respiratory-burst products from polymorphonuclear leukocytes in the antitumor activity of Propionibacterium acnes vaccine.
    Murano EA; Cummins CS
    Cancer Immunol Immunother; 1989; 29(1):7-16. PubMed ID: 2706641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.